
Other markets
As a multinational BioPharma company, we operate either directly or through distributor partners in many countries.  For contact information in the countries where Bristol Myers Squibb does not have a local office please contact our third party business partners from the drop-down menu.
Bosnia and Herzegovina
Bulgaria
Croatia
Cyprus
Egypt
Estonia
Iceland
Jordan
Israel
Latvia
Lebanon
Lithuania
Malta
Russia
Serbia
Slovakia
Slovenia
Venezuela
Ukraine
Bosnia and Herzegovina
Amicus Pharma d.o.o.
Fra Anđela Zvizdovića 1
71000 Sarajevo
Tel. +387 33 257 810
bih.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2021
Methodology Document 2021
Bulgaria
Swixx Biopharma EOOD
Sterling Serviced Office Group
48 Sitnyakovo Blvd.
Serdika center – 10th floor
Serdika Mall
1505 Sofia
Tel. +359 2 4942 480
bulgaria.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Bulgarian
Methodology Document 2020 -  English    Bulgarian
Croatia
Swixx Biopharma d.o.o.
Savska 32
10000 Zagreb
Tel. +385 1 2078 500 Tel. +385 1 2078 508
croatia.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Croatian
Methodology Document 2020 -  English    Croatian
Cyprus
Celgene Transparency Disclosures
EFPIA 2020 -  English    Greek
Methodology Document 2020 -  English    Greek
Estonia
Swixx Biopharma OÜ
Tornimäe 5 – 2
10145 Tallinn
Tel. +372 640 1030
estonia.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Estonian
Methodology Document 2020 -  English    Estonian
Egypt
Fattal Office/Medscience
48 Elhoreya St., Almaza, Heliopolis,
6th floor, Flat 12. Cairo-Egypt
Tel. +20224146784
Iceland
VISTOR
Horgatun 2
210 Gardabear, Island
http://vistor.is
BMS Transparency Disclosures
EFPIA 2021
Methodology Document 2021
Israel
Bristol Myers Squibb Israel
18 Aharon Bart St, PO BOX 3361,
Kiryat Arye, Petah Tikva
4951448, Israel
Tel. +972-3-5231021
Jordan
Orient Drug Store
P.O. Box 590, Nimer El Edwan St.
Jabal El Weibdeh El Gharbi, Amman 11118-Jordan
Tel. +96 26 465 2000
Latvia
Swixx BioPharma SIA
Valdemara iela 33 – 18A
Riga, LV-1010
Tel. +371 67708347
latvia.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Latvian
Methodology Document 2020 -  English    Latvian
Lebanon
Pacific Pharma
Hussein Oueyni st, Ras Beirut, Beirut, Lebanon
Tel. +961-1-806640 | +961-1-788976
Email:  pacific@terra.net.lb
Lithuania
Swixx Biopharma UAB
Bokšto 1-3
Vilnius
Tel. +370 5 236 9140
lithuania.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Lithuanian
Methodology Document 2020 -  English    Lithuanian
Malta
A.M. Mangion Ltd.
Mangion Building,
N/S off Valletta Road,
Luqa, LQA 6000, Malta
http://ammangion.com.mt
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Russia
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020
Methodology Document 2020
Serbia
Amicus SRB d.o.o.
Milorada Jovanovica
911000 Belgrade
Tel. +381 11 4426 300  Tel. +381 11 4426 301
serbia.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Serbian
Methodology Document 2020 -  English    Serbian
Slovakia
Swixx Biopharma s. r. o.
Regus Apollo Business Centre
Prievozská 4D, Blok E
Bratislava 821 09
Tel. +421 2 20833 600
slovakia.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Slovak
Methodology Document 2020 -  English    Slovak
Slovenia
Swixx Biopharma d.o.o.
Pot k sejmišču
351231 Ljubljana – Črnuče
Tel. +386 1 2355 100
slovenia.info@swixxbiopharma.com
BMS Transparency Disclosures
EFPIA 2022
Methodology Document 2022
EFPIA 2021
Methodology Document 2021
EFPIA 2020
Methodology Document 2020
Celgene Transparency Disclosures
EFPIA 2020 -  English    Slovak
Methodology Document 2020
Ukraine
BMS Transparency Disclosures
EFPIA 2021
Methodology Document 2021
Celgene Transparency Disclosures
EFPIA 2020
Methodology Document 2020
Venezuela
DROVITAL CASA DE REPRESENTACIÓN, C.A.
Oficina A, Planta Intermedia, Torre Financiera, Avenida Beethoven, Urbanización Colinas de Bello Monte,
Municipio Baruta, área metropolitana de Caracas, Venezuela.
Tel. +58 (212) 751 3202
Email:  blanca.berrios@drovitalcr.com

May 10, 2024
© 2024
Bristol-Myers Squibb Company